Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Resverlogix

A company developing epigenetic therapeuticsto treat heart disease, diabetes, chronic kidney disease and other illnesses

Overview Structured Data Issues Contributors Activity

resverlogix.com

Is a

Company

Organization

Company attributes

Industry

Consumer biotechnology

Biomedical engineering

...

Location

B2X

Founder

AngelList URL

Pitchbook URL

pitchbook.com/profiles.../53791-66

Legal Name

Resverlogix Corp.

Number of Employees (Ranges)

11 – 500

Email Address

info@resverlogix.com0

Full Address

535 Mission St, 14th Floor San Francisco, CA, USA, 941050

300, 4820 Richard Road SW Calgary, AB, CANADA, T3E 6L10

Investors

Yorkville Advisors

Founded Date

2001

Total Funding Amount (USD)

28,441,995

Latest Funding Round Date

August 14, 2013

Stock Symbol

RVX

Exchange

Toronto Stock Exchange

Latest Funding Type

Seed

Patents Assigned (Count)

Wellfound ID

Country

Headquarters

Other attributes

Company Operating Status

Active

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Resverlogix

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.